Picture of Nexstim Oyj logo

NXTMH Nexstim Oyj Share Price

0.000.00%
fi flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m+5.81%
3m-14.57%
6m-21.02%
1yr-43.77%
Volume Change (%)
10d/3m-5.93%
Price vs... (%)
52w High-42.53%
50d MA-4.05%
200d MA-15.57%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-19.07%
Return on Equity-38.45%
Operating Margin-16.95%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Nexstim Oyj EPS forecast chart

Profile Summary

Nexstim Oyj is a Finland-based medical technology company. It is focused on improving rehabilitation for stroke patients through the use of noninvasive brain stimulation. Its offering comprises: a diagnostic tool for brain surgery planning, Navigated Brain Stimulation (NBS) System, which comprises navigated transcranial magnetic stimulation (nTMS) device for presurgical mapping (PSM) of the motor and speech cortices; and a device for stroke therapy called Navigated Brain Therapy (NBT) System, which focuses stimulation on targeted locations in the brain in order to enhance rehabilitation process. The NBT System targets upper limb motor disability and is under Phase III pivotal clinical trial study at rehabilitation sites in the United States. The Company’s systems are used in over 100 facilities in research, therapy and neurosurgical planning purposes. Nexstim Oyj has two subsidiaries: Nexstim Inc and Nexstim Germany GmbH.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
October 25th, 2000
Public Since
November 14th, 2014
No. of Shareholders
7,638
No. of Employees
37
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
fi flag iconOMX Nordic Exchange - Helsinki
Shares in Issue
6,765,562

NXTMH Share Price Performance

Upcoming Events for NXTMH

Half Year 2024 Nexstim Oyj Earnings Release

Similar to NXTMH

Picture of BBS-Bioactive Bone Substitutes Oyj logo

BBS-Bioactive Bone Substitutes Oyj

fi flag iconOMX Nordic Exchange - Helsinki

Picture of Bioretec Oy logo

Bioretec Oy

fi flag iconOMX Nordic Exchange - Helsinki

Picture of DETECTION TECHNOLOGY Oyj logo

DETECTION TECHNOLOGY Oyj

fi flag iconOMX Nordic Exchange - Helsinki

Picture of Modulight Oyj logo

Modulight Oyj

fi flag iconOMX Nordic Exchange - Helsinki

Picture of Nightingale Health Oyj logo

Nightingale Health Oyj

fi flag iconOMX Nordic Exchange - Helsinki

FAQ